HCV Screening and Natural History

Volume 3, Issue 10.

David Thomas, MD, Professor of Medicine, and Director of the Division of Infectious Diseases at the Johns Hopkins University School of Medicine discusses HCV screening and natural history, in the form of case-study scenarios for the clinical practice.

Strategies For Intensifying Therapy For Glycemic Control

Volume 1, Issue 2.

Nestoras Mathioudakis, MD, Assistant Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism and Associate Director, Inpatient Diabetes Management at the Johns Hopkins University School of Medicine discusses glycemic control and strategies to intensify therapy in the format of case-study scenarios for the clinical practice.

What Does CFTR Tell Us About Lung Disease?

Volume 4, Issue 12.

In this issue our guest author is Dr. Patrick Sosnay, Assistant Professor at the Johns Hopkins Cystic Fibrosis Center. Dr. Sosnay will illustrate how the genetics of CF can be used to make a diagnosis or identify a CF carrier, predict how individuals with a given mutation will do clinically and allow clinicians to select currently available and hopefully future therapies that directly address the defect caused by their individual CFTR mutations.

Susanna Naggie, MD Discussed HBV and HCV Coverage at AASLD

Volume 3, Issue 8.

Susanna Naggie, MD, Professor, Assistant Professor of Medicine, Department of Medicine – Infectious Diseases at Duke University School of Medince discusses the development of new therapies for treating hepatitis C infection, and news about hepatitis B from the 64th meeting of the American Association for the Study of Liver Disease, as well as case-study scenarios for the clinical practice.

Behavioral Treatment to Improve Dietary Adherence and Weight Gain in Children with Cystic Fibrosis

Volume 4, Issue 10.

In this podcast we have guest author Lori Stark, PhD, ABPP, Professor of Pediatrics at the University of Cincinnati College of Medicine. Dr. Stark, discusses how to use “shaping” to encourage a child to eat a non-preferred food, describes the role of “attention” in maintaining behaviors incompatible with eating, and discusses the use of caloric goal-setting and dietary tracking applications to monitor treatment progress.

Cure of Hepatitis B: Is it Achievable?

Volume 3, Issue 6.

Dr. Fabien Zoulim, MD, PhD, Professor, head of INSERM Viral Hepatitis Laboratory at the Medical School of Lyon, Lyon 1 University, Hepatology Department, Hospices Civils de Lyon in Lyon, France discusses the topic of HBV cure, in the form of case-study scenarios for the clinical practice.

Highlights of the 27th Annual North American Cystic Fibrosis Conference

Special Edition 2014 – Steven Rowe.

In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses data findings from Dr. Steven Rowe results of the G551D observational study presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.

Highlights of the 27th Annual North American Cystic Fibrosis Conference

Special Edition 2014 – Steven Rowe.

In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses data findings from Dr. Steven Rowe results of the G551D observational study presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.

Highlights of the 27th Annual North American Cystic Fibrosis Conference

Special Edition 2014 – Scott Powers.

In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses findings from Dr. Scott Powers clinical trial on Behavioral & Nutrition Treatment for Preschoolers With CF which he presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.

Highlights of the 27th Annual North American Cystic Fibrosis Conference

Special Edition 2014 – Elizabeth Yen.

In this special edition of eCysticFibrosis Review, Dr. Peter Mogayzel discusses outcomes presented by Dr. Elizabeth during her presentation on Nutritional Status and Outcomes in Pediatrics CF presented at the 27th Annual North American Cystic Fibrosis Conference in Salt Lake City, Utah.